This is accompanied by PD-1, TIM-3, LAG-3, and CD39 expression in advanced cSCC, suggesting that stromal and regulatory signaling act synergistically to suppress cytotoxic T-cell infiltration and effector function. The gene discussed is ENTPD1; the disease is skin squamous cell carcinoma.